Encompass Health (EHC) Stock Forecast, Price & News

Encompass Health (NYSE:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health or view top-rated stocks.

Are investors shorting Encompass Health?

Encompass Health saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,650,000 shares, an increase of 25.6% from the April 15th total of 2,110,000 shares. Based on an average daily volume of 772,000 shares, the short-interest ratio is currently 3.4 days. Approximately 2.7% of the company's stock are short sold.
View Encompass Health's Short Interest.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Encompass Health.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) posted its quarterly earnings results on Wednesday, April, 27th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. The business earned $1.33 billion during the quarter, compared to the consensus estimate of $1.32 billion. Encompass Health had a trailing twelve-month return on equity of 17.99% and a net margin of 7.51%. Encompass Health's revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.05 EPS.
View Encompass Health's earnings history.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Thursday, May 5th. Investors of record on Wednesday, July 13th will be given a dividend of $0.28 per share on Wednesday, July 20th. This represents a $1.12 annualized dividend and a dividend yield of 1.72%. The ex-dividend date is Tuesday, July 12th.
View Encompass Health's dividend history.

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.75%. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY22 earnings guidance on Wednesday, April, 27th. The company provided earnings per share (EPS) guidance of $3.83-4.19 for the period, compared to the consensus EPS estimate of $4.11. The company issued revenue guidance of $5.38-5.50 billion, compared to the consensus revenue estimate of $5.45 billion.

What price target have analysts set for EHC?

8 brokers have issued 12 month price targets for Encompass Health's stock. Their forecasts range from $75.00 to $104.00. On average, they expect Encompass Health's stock price to reach $84.88 in the next year. This suggests a possible upside of 30.1% from the stock's current price.
View analysts' price targets for Encompass Health or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:

• Mr. Mark J. Tarr, CEO, Pres & Director (Age 60, Pay $3.04M)
• Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 60, Pay $1.65M)
• Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 57)
• Ms. Barbara Ann Jacobsmeyer, Chief Exec. Officer of Home Health & Hospice (Age 56)
• Ms. Elissa Joy Charbonneau, Chief Medical Officer (Age 62, Pay $676.46k) (LinkedIn Profile)
• Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54) (LinkedIn Profile)
• Mr. Rusty Yeager, Chief Information Officer & Sr. VP
• Mr. Mark Miller, Sr. VP of Investor Relations & Strategic Planning
• Ms. Dawn Rock, Chief Compliance Officer
• Mr. Anthony A. Hernandez, Chief HR Officer (Age 56)

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

Who are some of Encompass Health's key competitors?

Some companies that are related to Encompass Health include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Acadia Healthcare (ACHC), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Select Medical (SEM), U.S. Physical Therapy (USPH), National HealthCare (NHC), Brookdale Senior Living (BKD), Community Health Systems (CYH) and Five Star Senior Living (FVE).
View all of EHC's competitors.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (10.68%), Vanguard Group Inc. (9.40%), Wellington Management Group LLP (8.87%), Baupost Group LLC MA (3.01%), State Street Corp (2.74%) and Bank of New York Mellon Corp (2.10%). Company insiders that own Encompass Health stock include Andrew L Price, Elissa Joy Charbonneau, Kevin J O'connor and Terrance Williams.
View institutional ownership trends for Encompass Health.

Which institutional investors are selling Encompass Health stock?

EHC stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, TimesSquare Capital Management LLC, Royal Bank of Canada, Goldman Sachs Group Inc., Invesco Ltd., Prosight Management LP, UBS Group AG, and Mercer Global Advisors Inc. ADV.
View insider buying and selling activity for Encompass Health or view top insider-selling stocks.

Which institutional investors are buying Encompass Health stock?

EHC stock was acquired by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Empyrean Capital Partners LP, Paradice Investment Management LLC, Glenview Capital Management LLC, Bank of New York Mellon Corp, Kempen Capital Management N.V., Dimensional Fund Advisors LP, and Renaissance Technologies LLC. Company insiders that have bought Encompass Health stock in the last two years include Kevin J O'connor, and Terrance Williams.
View insider buying and selling activity for Encompass Health or or view top insider-buying stocks.

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $65.26.

How much money does Encompass Health make?

Encompass Health has a market capitalization of $6.51 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.909990 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,400 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.